Developing a Best Practice Guide for Leachables Risk Assessment, Study Design, and Analytical Methods
Posted on August 24, 2016
By: Kathryn McGohan, Scientist I
Bristol-Myers Squibb
Single-use systems (SUS) offer biopharmaceutical manufacturers significant gains in process flexibility, speed, and efficiency. Implementation of Single-Use Systems and components in biopharmaceutical manufacturing processes has increased rapidly in recent years. SUS are comprised of polymers, and t...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Analyitcal Methods, BPOG, Leachables, Single-use Systems, SUS
Related Product Videos
Is ADCC the biggest challenge to your biosimilar - Sartorius Stedim Biotech
ReadyToProcess™ prepacked columns - GE Healthcare Life Sciences
Related Products
Reliable supply, predictable performance - GE Healthcare Life SciencesFinesse
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
